XCE Tirzepatide is a novel GIP/GLP-1 receptor dual agonist currently being studied for its potential in glycemic control and weight management applications. Our pharmaceutical-grade XCE Tirzepatide is manufactured under strict quality control standards to ensure optimal purity and performance in research settings.
As a leading supplier of research compounds, we offer XCE Tirzepatide in various concentrations to meet different experimental requirements. The product is carefully packaged to maintain stability and comes with comprehensive analytical documentation.
XCE Tirzepatide works by simultaneously activating both the GIP and GLP-1 receptors, which may offer advantages over single-receptor agonists in certain research models. Researchers should note that this product is for laboratory use only and not intended for human consumption.